• Citer

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

par Croxford, J Ludovic;Pryce, Gareth;Jackson, Samuel J;Ledent, Catherine ;Giovannoni, Gavin;Pertwee, Roger G;Yamamura, Takashi;Baker, David
Référence Journal of neuroimmunology, 193, 1-2, page (120-129)
Publication Publié, 2008-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
Auteur:	Croxford, J Ludovic; Pryce, Gareth; Jackson, Samuel J; Ledent, Catherine; Giovannoni, Gavin; Pertwee, Roger G; Yamamura, Takashi; Baker, David
Informations sur la publication:	Journal of neuroimmunology, 193, 1-2, page (120-129)
Statut de publication:	Publié, 2008-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Cannabinoids
	Experimental autoimmune encephalomyelitis
	Immunosuppression
	Multiple sclerosis
	Neuroprotection
MeSH keywords:	Animals
	Benzoxazines -- pharmacology
	Cannabinoids -- pharmacology
	Cannabinoids -- therapeutic use
	Encephalomyelitis, Autoimmune, Experimental -- drug therapy
	Encephalomyelitis, Autoimmune, Experimental -- immunology
	Immunosuppressive Agents -- pharmacology
	Immunosuppressive Agents -- therapeutic use
	Mice
	Mice, Inbred C57BL
	Morpholines -- pharmacology
	Multiple Sclerosis -- drug therapy
	Multiple Sclerosis -- immunology
	Naphthalenes -- pharmacology
	Neuroprotective Agents -- pharmacology
	Neuroprotective Agents -- therapeutic use
	Piperidines -- pharmacology
	Pyrazoles -- pharmacology
	Receptor, Cannabinoid, CB1 -- physiology
	Receptor, Cannabinoid, CB2 -- physiology
	T-Lymphocytes -- drug effects
	T-Lymphocytes -- immunology
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0165-5728
	info:doi/10.1016/j.jneuroim.2007.10.024
	info:pii/S0165-5728(07)00396-7
	info:scp/37749034365
	info:pmid/18037503